S. Wingren

发表

Protein accumulation and gene mutation of p53 in bilateral breast cancer. South-East Sweden Breast Cancer Group.

M. Stenmark-Askmalm, M. Gentile, S. Wingren, 2001, Acta oncologica.

p53 and survival in early onset breast cancer: analysis of gene mutations, loss of heterozygosity and protein accumulation.

M. Gentile, S. Wingren, M. Bergman Jungeström, 1999, European journal of cancer.

CYP2D6 Genotype and Adjuvant Tamoxifen: Meta-Analysis of Heterogeneous Study Populations

M. Beckmann, P. Fasching, R. Altman, 2013, Clinical pharmacology and therapeutics.

Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry.

S. Wingren, O. Stål, S. Sullivan, 1994, Cytometry.

c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer.

L. Skoog, S. Wingren, O. Stål, 1995, European journal of cancer.

p53 polymorphic variants at codon 72 and the outcome of therapy in randomized breast cancer patients

S. Wingren, B. Nordenskjöld, L. Rutqvist, 2006, Pharmacogenetics and genomics.

Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer

S. Wingren, O. Stål, J. Carstensen, 2007, Breast Cancer Research.

Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients

L. Skoog, S. Wingren, O. Stål, 2005, Breast Cancer Research.

Candidate tumour suppressor genes at 11q23–q24 in breast cancer: evidence of alterations in PIG8, a gene involved in p53-induced apoptosis

M. Gentile, S. Wingren, Marie Ahnström, 2001, Oncogene.

Polymorphism in the manganese superoxide dismutase (MnSOD) gene and risk of breast cancer in young women

S. Wingren, Marie Ahnström, M. Bergman, 2005, Journal of Cancer Research and Clinical Oncology.

S‐phase fraction after gating on epithelial cells predicts recurrence in node‐negative breast cancer

S. Wingren, S. Sullivan, B. Nordenskjöld, 1994, International journal of cancer.

Association between CYP17 gene polymorphism and risk of breast cancer in young women

M. Gentile, S. Wingren, A. Lundin, 1999, International journal of cancer.

Frequent allelic losses on chromosome 13q in human male breast carcinomas.

M. Gentile, S. Wingren, K. Olsen, 1997, European journal of cancer.

The significance of MDM 2 SNP 309 and p 53 Arg 72 Pro in young women with breast cancer

S. Wingren, P. Wegman, A. Lång, 2022 .

Human malignant fibrous histiocytomas in vitro: growth characteristics and their association with expression of mRNA for platelet-derived growth factor, transforming growth factor-alpha and their receptors.

S. Wingren, T. Walz, Å. Wasteson, 1998, European journal of cancer.

Loss of cytokeratins in breast cancer cells using multiparameter DNA flow cytometry is related to both cellular factors and preparation procedure.

S. Wingren, O. Stål, B. Frånlund, 1995, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

Expression of the forkhead transcription factor FOXL2 correlates with good prognosis in breast cancer patients treated with tamoxifen.

S. Wingren, O. Stål, P. Wegman, 2011, International journal of oncology.

Suramin inhibits growth of human osteosarcoma xenografts in nude mice.

S. Wingren, T. Walz, Å. Wasteson, 1991, Cancer research.

Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women

S. Wingren, M. Bergman-Jungeström, 2001, British Journal of Cancer.

Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal breast cancer patients

S. Wingren, O. Stål, J. Carstensen, 2009 .

Sulfotransferase1A1 and risk of postmenopausal breast cancer.

S. Wingren, O. Stål, Piiha-Lotta Jerevall, 2005, Anticancer research.

Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma

H. Zhang, S. Wingren, O. Stål, 1992, The Lancet.

Flow cytometric DNA-heterogeneity in paraffin-embedded endometrial cancer.

S. Wingren, P. Rosenberg, C. Guerrieri, 1997, Acta oncologica.

Production of transforming growth factor alpha by human leukemia cells (HL-60 and U-937) during monocytic differentiation.

S. Wingren, T. Walz, Å. Wasteson, 1995, Leukemia.

ras p21 expression in relation to DNA ploidy, S-phase fraction and prognosis in colorectal adenocarcinoma.

H. Zhang, S. Wingren, O. Stål, 1991, European journal of cancer.

Correlation of DNA ploidy and S‐phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanoma

S. Aamdal, S. Wingren, J. Carstensen, 1996, International journal of cancer.

DNA ploidy and S-phase fraction as prognostic factors in patients with uveal melanomas.

S. Wingren, J. Carstensen, B. Kågedal, 1995, British Journal of Cancer.

Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin. South East Sweden Breast Cancer Group.

S. Wingren, O. Stål, B. Nordenskjöld, 1994, British Journal of Cancer.

Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma.

S. Wingren, X. Sun, J. Carstensen, 1996, European journal of cancer.

S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer.

A. Andersson, L. Skoog, S. Wingren, 1994, British Journal of Cancer.

In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients

S. Wingren, B. Nordenskjöld, P. Wegman, 2008, Breast Cancer Research and Treatment.

Flow cytometric gating on cytokeratin-containing DNA aneuploid breast cancer cells improves the prediction of recurrence.

S. Wingren, O. Stål, 1995, European journal of cancer.

Flow cytometric measurements of DNA index and S-phase on paraffin-embedded early stage endometrial cancer: an important prognostic indicator.

S. Wingren, O. Stål, B. Nordenskjöld, 1989, Gynecologic oncology.

Heterogeneity of squamous cell carcinomas of the oral cavity studied by flow cytometry.

S. Wingren, J. Olofsson, M. Tytor, 1991, Pathology, research and practice.

DNA ploidy and S-phase fraction in primary melanomas and their regional metastases

S. Wingren, J. Carstensen, B. Kågedal, 1994, Melanoma research.

S-phase determination of immunoselected cytokeratin-containing breast cancer cells improves the prediction of recurrence

S. Wingren, O. Stål, J. Carstensen, 1994, Breast Cancer Research and Treatment.

Ras p21 expression in relation to histopathological variables and prognosis in colorectal adenocarcinoma.

H. Zhang, S. Wingren, O. Stål, 1991, Acta oncologica.

Biological significance of allele specific loss of the p53 gene in breast carcinomas

S. Wingren, P. Wegman, Nashwan J. Marcus, 2009, Breast Cancer Research and Treatment.

ERBB2 and PTPN2 gene copy numbers as prognostic factors in HER2-positive metastatic breast cancer treated with trastuzumab

S. Wingren, O. Stål, N. Elander, 2019, Oncology letters.

Whole genome DNA methylation signature of HER2-positive breast cancer

S. Wingren, T. Nilsson, B. M. Lindqvist, 2014, Epigenetics.

DNA methylation pattern of the SLC25A43 gene in breast cancer

S. Wingren, T. Nilsson, S. Farkas, 2012, Epigenetics.

Effects of human platelet-derived growth factor-AB on sarcoma growth in vitro and in vivo.

S. Wingren, T. Walz, Å. Wasteson, 1999, Cancer letters.

DNA ploidy and S-phase in primary malignant melanoma as prognostic factors for stage III disease.

S. Wingren, J. Carstensen, B. Kågedal, 1993, British Journal of Cancer.

Wwox expression may predict benefit from adjuvant tamoxifen in randomized breast cancer patients.

S. Wingren, O. Stål, B. Nordenskjöld, 2013, Oncology reports.

Relationship of DNA ploidy and S-phase fraction to survival after first recurrence of breast cancer.

L. Skoog, S. Wingren, O. Stål, 1994, Acta oncologica.

Pancreatic hypertrophy with acinar cell nodules after longterm fundectomy in the rat.

J. Rehfeld, S. Wingren, S. Sullivan, 1993, Gut.

Deletion mapping of chromosome segment 11q24‐q25, exhibiting extensive allelic loss in early onset breast cancer

N. Loman, S. Wingren, S. Thorstenson, 2001, International journal of cancer.

The mitochondrial transporter SLC25A43 is frequently deleted and may influence cell proliferation in HER2-positive breast tumors

Zelmina Lubovac, S. Wingren, P. Wegman, 2012, BMC Cancer.

Hypermethylation of promoter regions of the APC1A and p16INK4a genes in relation to prognosis and tumor characteristics in cervical cancer patients.

S. Wingren, T. Nilsson, B. Sorbe, 2011, International journal of oncology.

Postprint Exploring the two-gene ratio in breast cancer – independent roles for HOXB 13 and IL 17 BR in prediction of clinical outcome

M. Fernö, S. Gruvberger-Saal, S. Wingren, 2008 .

Exploring the two-gene ratio in breast cancer—independent roles for HOXB13 and IL17BR in prediction of clinical outcome

M. Fernö, S. Gruvberger-Saal, S. Wingren, 2007, Breast Cancer Research and Treatment.

A comparative study of DNA cytometry methods for benign and malignant thyroid tissue.

J. Hrafnkelsson, S. Wingren, B. Nordenskjöld, 1988, American journal of clinical pathology.

p53 expression and the result of adjuvant therapy of breast cancer.

L. Skoog, S. Wingren, O. Stål, 1995, Acta oncologica.

Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer.

L. Skoog, S. Wingren, O. Stål, 1989, European journal of cancer & clinical oncology.

S-phase fraction is a prognostic factor in stage I breast carcinoma.

L. Skoog, S. Wingren, O. Stål, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group.

S. Wingren, P. Söderkvist, A. Lundin, 1999, Cancer research.

Frequent allelic losses at 11q24.1–q25 in young women with breast cancer: association with poor survival

M. Gentile, S. Wingren, K. Olsen, 1999, British Journal of Cancer.

C-erbB-2 overexpression and survival in early onset breast cancer

S. Wingren, K. Olsen, M. Agrup, 2000, Breast Cancer Research and Treatment.

DNA index and S-phase in primary brain tumors. A comparison between fresh and deparaffinized specimens studied by flow cytometry.

S. Wingren, J. Carstensen, B. Nordenskjöld, 1994, Journal of neurosurgery.

Comparison of static and flow cytofluorometry for estimation of DNA index and S-phase fraction in fresh and paraffin-embedded breast carcinoma tissue.

S. Wingren, O. Stål, B. Nordenskjöld, 1988, Acta oncologica.

Incidence and prognosis in early onset breast cancer.

S. Wingren, B. Nordenskjöld, L. Brudin, 2002, Breast.

Contraction of Collagen Lattices by Cells from Dupuytren’s Nodules

S. Wingren, L. Franzén, M. Ågren, 1996, Journal of hand surgery.

DNA content and S-phase fraction in male breast carcinomas.

S. Wingren, J. Carstensen, T. Hatschek, 1994, Acta oncologica.

HER4 tumor expression in breast cancer patients randomized to treatment with or without tamoxifen.

K. Fransén, S. Wingren, O. Stål, 2015, International journal of oncology.

A Mechanistic Hypothesis for the Cytochrome P450-Catalyzed Cis-Trans Isomerization of 4-Hydroxytamoxifen: An Unusual Redox Reaction

Leif A. Eriksson, Li Gao, Yaoquan Tu, 2011, J. Chem. Inf. Model..

Heterogeneity of salivary gland tumors studied by flow cytometry

P. Lundquist, S. Wingren, B. Nordenskjöld, 1993, Head & neck.

Rapid typing of neonatal Staphylococcus epidermidis isolates using polymerase chain reaction for repeat regions in surface protein genes

B. Söderquist, S. Wingren, M. Björkqvist, 2010, European Journal of Clinical Microbiology and Infectious Diseases.

Wwox expression may predict benefit from adjuvant tamoxifen in randomized breast cancer patients.

S. Wingren, O. Stål, B. Nordenskjöld, 2013, Oncology reports.